Search

everythinglearnresearchcommunity

for

Search:↓

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

A new gel containing minoxidil can treat hair loss effectively, potentially reducing side effects and improving treatment.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Steroid 5α-reductase evolved from protists and diversified in eukaryotes, with specific roles in mammals and plants.

The gel made of minoxidil and hydroxypropyl-β-cyclodextrin improves hair growth and is good for long-term use.

The new device improves surgical accuracy by using a special dye and camera to see inside tissues.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Improving artificial vascular grafts requires better materials and surface designs to reduce blood clotting and support blood vessel cell growth.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Hair problems can be caused by genetics or the environment, and treatment should focus on the cause and reducing hair damage.

Trichoscopy is a useful tool for diagnosing hair disorders without pulling out hair.

Stem cell therapy could help regenerate inner ear hair cells to treat hearing loss.

NIPT can help detect potential maternal cancer, and GIPXplore can identify immune diseases in pregnancies.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Plasmatherapy improves immune status in vitiligo patients, especially those with segmental vitiligo.

New gel formulas without ethanol and propylene glycol, containing a minoxidil-methyl-β-cyclodextrin complex, have been created for treating hair loss.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

The InCISE score is a promising tool for assessing wound healing in head and neck surgery but needs more research for broader use.

Dyes can penetrate human skin and hair follicles up to 1.2 mm deep and the sebaceous gland can store dye; Indocyanine Green lotion was made for safe dyeing and monitoring.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

Patients with Complete Androgen Insensitivity Syndrome need psychological support and multidisciplinary care for complex treatment decisions.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

Ixekizumab has known and some unexpected side effects.

The G60S Connexin43 mutation causes hair growth issues and poor hair quality in mice, similar to human ODDD patients.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

Connexin-26 gene mutations may increase cancer risk in KID syndrome patients.

Near-infrared laser therapy with Indocyanine Green dye improves acne by reducing inflammation without side effects.